Diabetes Mellitus, Type 2 Clinical Trials in Gilbert, Arizona

3 studies are recruiting for diabetes mellitus, type 2 in Gilbert, Arizona right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

    The purpose of this clinical study is to look at the safety and tolerability of switching from semaglutide to CagriSema, for participants who have type 2 diabetes. All participants will get CagriSema, the treatment being tested. Participants will be in this clinical study for about 6 months.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Gilbert Center For Family Medicine, Gilbert, Arizona
    Locations
    40 in total
    Run by
    Novo Nordisk A/S

    See if you can join NCT07817251 on ClinicalTrials.gov

  2. A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

    The purpose of this study is to investigate weight reduction with macupatide and eloralintide, alone or in combination, in adult participants with obesity or overweight and with type 2 diabetes. Participation in the study will last about 48 weeks.

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC, Gilbert, Arizona
    Locations
    42 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07215559 on ClinicalTrials.gov

  3. Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

    The primary objective of this trial is to evaluate the long-term efficacy, safety, and tolerability of maridebart cafraglutide in participants with obesity and type 2 diabetes mellitus. Trial 20210182 is extension of trial 20210184 (NCT06858878).

    Stage
    Phase 3
    Ages
    18 to 99
    Site
    Gilbert Center for Family Medicine, Gilbert, Arizona
    Locations
    37 in total
    Run by
    Amgen

    See if you can join NCT07684144 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.